Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Paintaud

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
La Revue Du Praticien|October 27, 1997
[Dose-effect relationship in drug prescription]G Paintaud
Journal of Hepatology|March 1, 1991
Diagnostic tools in liver allograft rejectionG Paintaud, J P Miguet
British Journal of Clinical Pharmacology|March 1, 1993
The reproducibility of quinine bioavailabilityG Paintaud, G Alván, O Ericsson
Clinical Pharmacokinetics|September 18, 1998
Methodological issues in pharmacokinetic-pharmacodynamic modellingE Bellissant, V Sébille, G Paintaud
Clinical Pharmacokinetics|June 29, 1999
The efficiency concept in pharmacodynamicsG Alván, G Paintaud, M Wakelkamp
British Journal of Clinical Pharmacology|May 1, 1997
Natriuretic efficiency of frusemide as a consequence of drug input rateM Wakelkamp, G Alván, G Paintaud
British Journal of Clinical Pharmacology|March 7, 1998
The time of maximum effect for model selection in pharmacokinetic-pharmacodynamic analysis applied to frusemideM Wakelkamp, G Alván, G Paintaud
Annals of the Rheumatic Diseases|May 14, 2008
Rituximab-related late-onset neutropenia in a patient with severe rheumatoid arthritisH Marotte, G Paintaud, H Watier, et al.
Intensive Care Medicine|August 17, 2000
Delayed toxicity in acute ethanol-methanol copoisoning in a chronic alcohol abuser: usefulness of continuous 4-methylpyrazole (fomepizole) infusionE Hazouard, M Ferrandière, G Paintaud, et al.
European Journal of Clinical Pharmacology|January 1, 1993
Dose proportional absorption of 25-150 mg atenololM Wakelkamp, G Alván, G Paintaud, et al.
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
La Revue Du Praticien|October 27, 1997
[Dose-effect relationship in drug prescription]G Paintaud
Journal of Hepatology|March 1, 1991
Diagnostic tools in liver allograft rejectionG Paintaud, J P Miguet
British Journal of Clinical Pharmacology|March 1, 1993
The reproducibility of quinine bioavailabilityG Paintaud, G Alván, O Ericsson
Clinical Pharmacokinetics|September 18, 1998
Methodological issues in pharmacokinetic-pharmacodynamic modellingE Bellissant, V Sébille, G Paintaud
Clinical Pharmacokinetics|June 29, 1999
The efficiency concept in pharmacodynamicsG Alván, G Paintaud, M Wakelkamp
British Journal of Clinical Pharmacology|May 1, 1997
Natriuretic efficiency of frusemide as a consequence of drug input rateM Wakelkamp, G Alván, G Paintaud
British Journal of Clinical Pharmacology|March 7, 1998
The time of maximum effect for model selection in pharmacokinetic-pharmacodynamic analysis applied to frusemideM Wakelkamp, G Alván, G Paintaud
Annals of the Rheumatic Diseases|May 14, 2008
Rituximab-related late-onset neutropenia in a patient with severe rheumatoid arthritisH Marotte, G Paintaud, H Watier, et al.
Intensive Care Medicine|August 17, 2000
Delayed toxicity in acute ethanol-methanol copoisoning in a chronic alcohol abuser: usefulness of continuous 4-methylpyrazole (fomepizole) infusionE Hazouard, M Ferrandière, G Paintaud, et al.
European Journal of Clinical Pharmacology|January 1, 1993
Dose proportional absorption of 25-150 mg atenololM Wakelkamp, G Alván, G Paintaud, et al.
Pageof 7